---
figid: PMC4693579__BCP-81-078-g002
figlink: /pmc/articles/PMC4693579/figure/bcp12777-fig-0002/
number: F2
caption: GLP‐1 and Wnt signalling in the regulation of bone formation (A) In the inactive
  state of the Wnt/β‐catenin pathway, Wnt is inhibited by a decoy receptor sFRP, where
  as its co‐receptor LRP5/6 binds to inhibitory protein sclerostin or Dkk. Activated
  GSK‐3β can result in proteosomal degradation of β‐catenin, which then inhibits osteoblast
  differentiation. Specific gene expression of adipocyte differentiation including
  PPARγ, C/EBPα, and LPL and bone formation negative regulatory genes SOST increased
  but bone formation positive regulatory genes including Runx2/cbfa1, OPG, and OC
  decreased. (B) The Wnt/β‐catenin pathway is activated by the binding of the Wnt
  to a co‐receptor complex LRP5/6 and frizzled family member. Disruption of the GSK‐3β
  inhibitory complex stabilizes the β‐catenin, which is then translocated into the
  nucleus and activates transcription. GLP‐1 could also stabilize β‐catenin by binding
  to its receptor and increasing the level of intracellular cAMP. The changes in the
  expression of related genes are the opposite of Figure A. sFRP secreted frizzled
  related protein; Dsh dishevelled; LRP5/6 lipoprotein receptor related proteins 5
  and 6; Dkk1 dickkopf1; APC adenomatous polyposis coli; GSK‐3β glycogen synthesis
  kinase‐3β; Frat1 frequently rearranged in advanced T‐cell lymphomas‐1; cAMP cyclic
  adenosine monophosphate; TCF/LEF T‐cell factor/lymphoid enhancing factor; PPARγ
  peroxisome proliferator‐activated receptorγ; C/EBPα CCAAT/enhancer‐binding protein
  α; LPL lipoprotein lipase; SOST sclerostin; Runx2/cbfa1 runt‐related transcription
  factor 2/core binding factor alpha1; OPG osteoprotegerin; OC osteocalcin
pmcid: PMC4693579
papertitle: 'Glucagon‐like peptide‐1(GLP‐1) receptor agonists: potential to reduce
  fracture risk in diabetic patients?.'
reftext: Guojing Luo, et al. Br J Clin Pharmacol. 2016 Jan;81(1):78-88.
pmc_ranked_result_index: '36353'
pathway_score: 0.9589481
filename: BCP-81-078-g002.jpg
figtitle: GLP‐1 and Wnt signalling in the regulation of bone formation (A) In the
  inactive state of the Wnt/B‐catenin pathway, Wnt is inhibited by a decoy receptor
  sFRP, where as its co‐receptor LRP5/6 binds to inhibitory protein sclerostin or
  Dkk
year: '2016'
organisms: Homo sapiens
ndex: ee501054-deb6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4693579__BCP-81-078-g002.html
  '@type': Dataset
  description: GLP‐1 and Wnt signalling in the regulation of bone formation (A) In
    the inactive state of the Wnt/β‐catenin pathway, Wnt is inhibited by a decoy receptor
    sFRP, where as its co‐receptor LRP5/6 binds to inhibitory protein sclerostin or
    Dkk. Activated GSK‐3β can result in proteosomal degradation of β‐catenin, which
    then inhibits osteoblast differentiation. Specific gene expression of adipocyte
    differentiation including PPARγ, C/EBPα, and LPL and bone formation negative regulatory
    genes SOST increased but bone formation positive regulatory genes including Runx2/cbfa1,
    OPG, and OC decreased. (B) The Wnt/β‐catenin pathway is activated by the binding
    of the Wnt to a co‐receptor complex LRP5/6 and frizzled family member. Disruption
    of the GSK‐3β inhibitory complex stabilizes the β‐catenin, which is then translocated
    into the nucleus and activates transcription. GLP‐1 could also stabilize β‐catenin
    by binding to its receptor and increasing the level of intracellular cAMP. The
    changes in the expression of related genes are the opposite of Figure A. sFRP
    secreted frizzled related protein; Dsh dishevelled; LRP5/6 lipoprotein receptor
    related proteins 5 and 6; Dkk1 dickkopf1; APC adenomatous polyposis coli; GSK‐3β
    glycogen synthesis kinase‐3β; Frat1 frequently rearranged in advanced T‐cell lymphomas‐1;
    cAMP cyclic adenosine monophosphate; TCF/LEF T‐cell factor/lymphoid enhancing
    factor; PPARγ peroxisome proliferator‐activated receptorγ; C/EBPα CCAAT/enhancer‐binding
    protein α; LPL lipoprotein lipase; SOST sclerostin; Runx2/cbfa1 runt‐related transcription
    factor 2/core binding factor alpha1; OPG osteoprotegerin; OC osteocalcin
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CTNNB1
  - RUNX2
  - WNT3
  - WNT16
  - AXIN1
  - AXIN2
  - PLXNA2
  - LYPLA1
  - WNT7B
  - APC
  - WNT5B
  - WNT3A
  - FZD2
  - GSK3A
  - WNT4
  - FRAT1
  - FZD5
  - LRP5
  - LRP6
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - FZD4
  - FZD10
  - WNT6
  - WNT7A
  - GSK3B
  - KREMEN1
  - LPL
  - FZD3
  - FZD1
  - WNT11
  - WNT2B
  - WNT9A
  - TNFRSF11B
  - SOST
  - WNT8A
  - WNT2
  - WNT5A
  - WNT10B
  - WNT1
  - WNT9B
  - WNT10A
  - WNT8B
  - Cancer
genes:
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: AYRunx2/cbfa1
  symbol: CBFA1
  source: hgnc_prev_symbol
  hgnc_symbol: RUNX2
  entrez: '860'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: OCt
  symbol: OCT
  source: hgnc_alias_symbol
  hgnc_symbol: PLXNA2
  entrez: '5362'
- word: LPL1
  symbol: LPL1
  source: hgnc_alias_symbol
  hgnc_symbol: LYPLA1
  entrez: '10434'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: Frat-1
  symbol: FRAT1
  source: hgnc_symbol
  hgnc_symbol: FRAT1
  entrez: '10023'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: LRP5
  symbol: LRP5
  source: hgnc_symbol
  hgnc_symbol: LRP5
  entrez: '4041'
- word: LRP5/6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Kremen
  symbol: KREMEN
  source: hgnc_prev_symbol
  hgnc_symbol: KREMEN1
  entrez: '83999'
- word: LPL
  symbol: LPL
  source: hgnc_symbol
  hgnc_symbol: LPL
  entrez: '4023'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: OPG
  symbol: OPG
  source: hgnc_prev_symbol
  hgnc_symbol: TNFRSF11B
  entrez: '4982'
- word: Runx2/cbfa1
  symbol: RUNX2
  source: hgnc_symbol
  hgnc_symbol: RUNX2
  entrez: '860'
- word: SOST
  symbol: SOST
  source: hgnc_symbol
  hgnc_symbol: SOST
  entrez: '50964'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4693579__F2
redirect_from: /figures/PMC4693579__F2
figtype: Figure
---
